Anthropic signs a USD 35bln cloud deal backed by NVIDIA (NVDA), with NVIDIA to supply the chips to the Texas data centre and hold the lease, according to WSJ
Newsquawk Staff ·
Anthropic signs a USD 35bln cloud deal backed by NVIDIA (NVDA), with NVIDIA to supply the chips to the Texas data centre and hold the lease, according to WSJ.
What it means
Deals of this shape sit in the AI infrastructure pattern where the chip supplier is not only selling hardware but also underwriting the demand side by holding the lease, a structure that echoes earlier capex cycles in which vendors financed customers to accelerate adoption. The key distinction is between compute demand that is genuinely incremental and capacity that is being pulled forward or circularly supported by the supplier, since the former reads as broader utilization while the latter raises questions about revenue quality and obligations sitting close to the vendor. For NVIDIA the transmission channel runs through data center revenue visibility, supply allocation into a Texas build, and any lease or financing exposure that blurs the line between customer and landlord; for Anthropic it is secured access to scarce accelerators without owning the full balance sheet burden. Precedent in these arrangements is that the first market focus is the headline size, here USD 35bln, but the durable read comes from contract length, take-or-pay terms, power and interconnection arrangements, and whether capacity is exclusive or fungible across cloud customers. Follow-ons are confirmation in NVIDIA disclosures, peer cloud capex commentary, Texas power availability, and any sign that similar supplier-backed leases are being replicated across the AI complex.
Sources
- Daily US Earnings Estimates: 26th October 2026: VZ, WELL
- Moonshot AI unveils 2.8tln-parameter Kimi K3.1 Pro model; says it beats Opus 5.5 and GPT-6 Astra on long-horizon coding tasks and scores top marks on SWE Marathon and agent benchmarks; pledges open weights for the 3tln-class model by November 4th
- The Trump administration plans to introduce voluntary “US Caught Seafood” labels to help consumers identify seafood origins, according to CBS
- Bristol Myers Squibb (BMY) spokesperson says the company has identified the cause of an earlier Car-T safety signal; will look to resume the paused trials in 2027
- OpenAI reveals plans for an in-house exabyte-scale storage system
Related headlines
- Republican Senator Blackburn has raised concerns about Meta’s (META) plans to update its commercial terms, warning that the changes could “exploit American creators and businesses,” according to a letter2 hours ago
- Upside in Penguin Solutions (PEGN) attributed to M&A chatter - UNCONFIRMED 2 hours ago
- CrowdStrike (CRWD) CEO says in the coming months we will see a lot of breaches from the PHP vulnerability3 hours ago
- US President Trump says Elon Musk will not do anything wrong regarding access to Starlink (SPCX) in Ukraine3 hours ago
- CNBC speculates that Verizon (VZ) would most likely be involved in the context of a partnership with SpaceX (SPCX)3 hours ago
- Ukraine President Zelensky says the Tesla (TSLA)/SpaceX (SPCX) Starlink and Starshield service remains slowed3 hours ago
- US EQUITY OPEN: Breadth poor at the open: Energy leads gains on oil rally, Tech sees slight bounce4 hours ago
- Meta (META) says it will extend the implementation date of updated commercial terms to November 20th (prev. October 30th); extension will allow it to explain the changes to partners and stakeholders5 hours ago
- Abbott (ABT) presents new ESMO data showing 30% absolute improvement in sensitivity with the whole-genome sequencing Oncodetect test in colorectal cancer5 hours ago
- Daily US Equity Opening News: SPCX explores access to 80K US cell sites; OpenAI nears USD 30bln funding at $1.25T valuation5 hours ago
- American Express (AXP) to cut 5% of jobs5 hours ago
- US BROKER MOVES: HESM upgraded at Raymond James; NCLH downgraded at JPM5 hours ago
- Oracle (ORCL) to invest USD 1bln in partner ecosystem over 4 years6 hours ago
- Bristol-Myers Squibb (BMY) says Iza-Bren reduced the risk of progression or death by 59% in Phase 3 breast cancer study; median PFS 8.2 months vs 4.0 months for chemotherapy; cORR 40.5% vs 20.2%; mDOR 6.9 vs 4.2 months6 hours ago
- American Express (AXP) Q3 2026 (USD): EPS 5.42 (exp. 4.50), Revenue 20.1bln (exp. 20.1bln)7 hours ago